<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Addiction</journal-id><journal-id journal-id-type="iso-abbrev">Addiction</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Addiction (Abingdon, England)</journal-title></journal-title-group><issn pub-type="ppub">0965-2140</issn><issn pub-type="epub">1360-0443</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10683938</article-id><article-id pub-id-type="pmcid-ver">PMC10683938.1</article-id><article-id pub-id-type="pmcaid">10683938</article-id><article-id pub-id-type="pmcaiid">10683938</article-id><article-id pub-id-type="manuscript-id">NIHMS1941819</article-id><article-id pub-id-type="pmid">35652681</article-id><article-id pub-id-type="doi">10.1111/add.15959</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1941819</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1941819</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Duration of Medication Treatment for Opioid-Use Disorder and Risk of Overdose among Medicaid Enrollees in Eleven States: A Retrospective Cohort Study</article-title><subtitle>Writing Committee on behalf of Medicaid Outcomes Distributed Research Network</subtitle></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Burns</surname><given-names initials="M">Marguerite</given-names></name><degrees>PhD</degrees><xref rid="CR1" ref-type="corresp">*</xref><aff id="A1">Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin, Madison, WI</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tang</surname><given-names initials="L">Lu</given-names></name><degrees>PhD</degrees><aff id="A2">Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chang</surname><given-names initials="CCH">Chung-Chou H.</given-names></name><degrees>PhD</degrees><aff id="A3">Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="JY">Joo Yeon</given-names></name><degrees>MS</degrees><aff id="A4">Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ahrens</surname><given-names initials="K">Katherine</given-names></name><degrees>PhD</degrees><aff id="A5">Public Health Program, Muskie School of Public Service, University of Southern Maine, Portland, ME</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Allen</surname><given-names initials="L">Lindsay</given-names></name><degrees>PhD</degrees><aff id="A6">Health Policy, Management, and Leadership Department, School of Public Health, West Virginia University, Morgantown, WV</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cunningham</surname><given-names initials="P">Peter</given-names></name><degrees>PhD</degrees><aff id="A7">Health Behavior and Policy Department, School of Medicine, Virginia Commonwealth University, Richmond, VA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gordon</surname><given-names initials="AJ">Adam J.</given-names></name><degrees>MD, MPH</degrees><aff id="A8">Department of Medicine and Department of Psychiatry, School of Medicine, University of Utah, Salt Lake City, UT</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jarlenski</surname><given-names initials="MP">Marian P.</given-names></name><degrees>PhD</degrees><aff id="A9">Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lanier</surname><given-names initials="P">Paul</given-names></name><degrees>PhD</degrees><aff id="A10">School of Social Work, University of North Carolina at Chapel Hill, Chapel Hill, NC</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mauk</surname><given-names initials="R">Rachel</given-names></name><degrees>PhD</degrees><aff id="A11">Government Resource Center, Ohio Colleges of Medicine, The Ohio State University, Columbus, OH</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>McDuffie</surname><given-names initials="MJ">Mary Joan</given-names></name><degrees>MA</degrees><aff id="A12">Center for Community Research &amp; Service, Biden School of Public Policy and Administration, University of Delaware, Newark, DE</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mohamoud</surname><given-names initials="S">Shamis</given-names></name><degrees>MA</degrees><aff id="A13">The Hilltop Institute, University of Maryland Baltimore County, Baltimore, MD</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Talbert</surname><given-names initials="J">Jeffery</given-names></name><degrees>PhD</degrees><aff id="A14">Division of Biomedical Informatics, College of Medicine, University of Kentucky, Lexington, KY</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zivin</surname><given-names initials="K">Kara</given-names></name><degrees>PhD, MS, MA</degrees><aff id="A15">Department of Psychiatry, University of Michigan Medical School, Ann Arbor, MI</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Donohue</surname><given-names initials="J">Julie</given-names></name><degrees>PhD</degrees><aff id="A16">Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA</aff></contrib></contrib-group><author-notes><corresp id="CR1"><label>*</label>Corresponding Author: Marguerite Burns, PhD; Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Room 760A WARF Building, Madison, WI 53726; <email>meburns@wisc.edu</email>; 608-265-8527.</corresp><fn fn-type="COI-statement" id="FN1"><p id="P37">Conflict of interest declaration: None</p></fn></author-notes><pub-date pub-type="ppub"><month>12</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>13</day><month>6</month><year>2022</year></pub-date><volume>117</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">449882</issue-id><fpage>3079</fpage><lpage>3088</lpage><pub-history><event event-type="nihms-submitted"><date><day>10</day><month>11</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>28</day><month>11</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>28</day><month>11</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 16:25:15.287"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1941819.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background and Aims.</title><p id="P1">Medication for opioid use disorder (MOUD) reduces harms associated with opioid use disorder (OUD), including risk of overdose. Understanding how variation in MOUD duration influences overdose risk is important as health care payers increasingly remove barriers to treatment continuation (e.g., prior authorization). This study measured the association between MOUD continuation, relative to discontinuation, and opioid-related overdose among Medicaid beneficiaries.</p></sec><sec id="S2"><title>Design.</title><p id="P2">Retrospective cohort study using landmark survival analysis. We estimated the association between treatment continuation and overdose risk at 5 points after the index, or first, MOUD claim. Censoring events included death and disenrollment.</p></sec><sec id="S3"><title>Setting.</title><p id="P3">Medicaid programs in eleven US states: Delaware, Kentucky, Maryland, Maine, Michigan, North Carolina, Ohio, Pennsylvania, Virginia, West Virginia, and Wisconsin.</p></sec><sec id="S4"><title>Participants.</title><p id="P4">293,180 Medicaid beneficiaries aged 18&#8211;64 with a diagnosis of OUD and had a first MOUD claim between 2016 &#8211; 2017.</p></sec><sec id="S5"><title>Measurements.</title><p id="P5">MOUD formulations included methadone, buprenorphine, and naltrexone. We measured medically-treated opioid-related overdose within claims within 12-months of the index MOUD claim.</p></sec><sec id="S6"><title>Findings.</title><p id="P6">Results were consistent across states. In pooled results, 5.1% of beneficiaries had an overdose, and 67% discontinued MOUD before an overdose or censoring event within 12-months. Beneficiaries who continued MOUD beyond 60 days had a lower relative hazard of overdose (HR), compared with those who discontinued by day 60, (HR .39; 95% confidence interval [CI], .36-.42; P &lt;.0001). MOUD continuation was associated with lower overdose risk at 120 days (HR .34; 95% CI, .31-.37; P &lt;.0001), 180 days (HR .31; 95% CI, .29-.34; P &lt;.0001), 240 days (HR .29; 95% CI, .26-.31; P &lt;.0001), and 300 days (HR .28; 95% CI, .24-.32; P &lt;.0001). The hazard of overdose was 10% lower with each additional 60 days of MOUD (95% CI, .88-.92; P &lt; .0001).</p></sec><sec id="S7"><title>Conclusions.</title><p id="P7">Continuation of medication for opioid use disorder (MOUD) in US Medicaid beneficiaries was associated with a substantial reduction in overdose risk up to 12 months after the first claim for MOUD.</p></sec></abstract><kwd-group><kwd>medication for opioid use disorder</kwd><kwd>opioid use disorder</kwd><kwd>opioid-related overdose</kwd><kwd>Medicaid</kwd><kwd>landmark survival analysis</kwd><kwd>distributed research network</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>